MYC and B-cell non-Hodgkin lymphoma: However, in vitro data characterizing the effects of metformin on mitochondrial respiration and cellular metabolism in B-cell lymphomas remains relatively rudimentary while the differential therapeutic effects of metformin across various histologic subtypes of aggressive B-cell lymphomas and according to c-MYC status has yet to be explored.